The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Tailored Home-Based Exercise Program for Multiple Chronic Conditions
- Conditions
- CancerHypertensionDiabetes
- Interventions
- Other: Tailored Technology-Enhance Home-based exercise program (iHBE)
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2022-09-21
- Target Recruit Count
- 34
- Registration Number
- NCT03874754
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Selective Transvenous Chemoembolization of Primary Pancreatic Tumors
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Drug: Retrograde venous infusion of gemcitabine/lipiodol
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Automated Method for Breast Cancer Detection
- Conditions
- Breast Cancer Diagnosis
- Interventions
- Procedure: Fine needle aspirationDevice: Cancer Detection cartridge
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2021-11-19
- Target Recruit Count
- 116
- Registration Number
- NCT03863522
- Locations
- 🇺🇸
Johns Hopkins Hospital Outpatient Center, Baltimore, Maryland, United States
🇺🇸Johns Hopkins Medical Imaging at Green spring Station, Lutherville-Timonium, Maryland, United States
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Focal brachytherapy with PSMA PET imaging
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2025-01-10
- Target Recruit Count
- 20
- Registration Number
- NCT03861676
- Locations
- 🇺🇸
SKCCC at Johns Hopkins, Baltimore, Maryland, United States
Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma
- Conditions
- GliosarcomaGlioma
- Interventions
- Procedure: APT MRI
- First Posted Date
- 2019-02-18
- Last Posted Date
- 2019-11-26
- Target Recruit Count
- 13
- Registration Number
- NCT03843814
- Locations
- 🇺🇸
The SKCCC at Johns Hopkins, Baltimore, Maryland, United States
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2021-12-15
- Target Recruit Count
- 23
- Registration Number
- NCT03793543
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)
- Conditions
- Vulvar DiseasesHPV-Related Vulvar Intraepithelial NeoplasiaVulvar DysplasiaVulva Intraepithelial NeoplasiaPreinvasive Vulvar Disease
- Interventions
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 15
- Registration Number
- NCT03792516
- Locations
- 🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
🇺🇸Cleveland Clinic Fairview Hospital, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Foundation - Main Campus, Cleveland, Ohio, United States
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
- Conditions
- Renal Cell CarcinomaKidney Cancer MetastaticMetastatic Renal Cell CarcinomaRenal CarcinomaKidney Cancer
- Interventions
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2025-03-13
- Target Recruit Count
- 20
- Registration Number
- NCT03786796
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
- Conditions
- Resectable Biliary Tract Cancer
- Interventions
- Drug: Cabrilizumab